Breast Cancer

, Volume 24, Issue 3, pp 491–492

Disease-free interval in metastatic breast cancer patients undergoing complete remission: implications of cross-sectional study design and biologic considerations about disease history

Author’s reply


  1. 1.
    Galli G, Tessari A, Porcu L, Bregni G, Paolini B, Carcangiu ML, et al. Complete remission in metastatic breast cancer: expecting the unexpected—results of a cross-sectional study. Breast Cancer. 2017. doi:10.1007/s12282-017-0751-6 [Epub ahead of print].
  2. 2.
    Altundag K. Does longer disease free interval affect the complete remission in metastatic breast cancer? Breast Cancer. 2017;16:1–1 [Epub ahead of print].Google Scholar
  3. 3.
    Hudson JI, Pope HG Jr, Glynn RJ. The cross-sectional cohort study: an underutilized design. Epidemiology. 2005;16(3):355–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Loibl S, von Minckwitz G, Untch M, Denkert C, German Breast Group C. Predictive factors for response to neoadjuvant therapy in breast cancer. Oncol Res Treat. 2014;37(10):563–8.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Breast Cancer Society 2017

Authors and Affiliations

  1. 1.Department of Medical OncologyFondazione IRCCS Istituto Nazionale dei TumoriMilanItaly
  2. 2.Department of Cancer Biology and GeneticsThe Ohio State UniversityColumbusUSA

Personalised recommendations